267 related articles for article (PubMed ID: 7026384)
1. [Effect of drugs and poisons on the synthesis and activity of microsomal enzymes participating in their metabolism].
Hanke J
Folia Med Cracov; 1980; 22(3-4):263-78. PubMed ID: 7026384
[No Abstract] [Full Text] [Related]
2. [Cytochrome P-450: the effect of drugs and poisons].
Chekman IS; Grinevich AI
Farmakol Toksikol; 1984; 47(1):119-23. PubMed ID: 6705899
[No Abstract] [Full Text] [Related]
3. [P-450 cytochrome. Detoxication by liver microsomes].
Gajdos A
Nouv Presse Med; 1972 Jun; 1(23):1587-92. PubMed ID: 4402521
[No Abstract] [Full Text] [Related]
4. Perinatal drug metabolism and morphological changes in the hepatocytes of normal and phenobarbital-treated guinea pigs.
Kuenzig W; Kamm JJ; Boublik M; Jenkins F; Burns JJ
J Pharmacol Exp Ther; 1974 Oct; 191(1):32-44. PubMed ID: 4153895
[No Abstract] [Full Text] [Related]
5. [Effect of ionizing radiation on the activity of drug-metabolizing enzymes of the endoplasmic reticulum (review of the literature)].
Khalilov EM; Bol'shev VN
Farmakol Toksikol; 1976; 39(4):500-6. PubMed ID: 17548
[No Abstract] [Full Text] [Related]
6. A comparative study of xenobiotic-metabolizing enzymes in liver and intestine of various animal species.
Chhabra RS; Pohl RJ; Fouts JR
Drug Metab Dispos; 1974; 2(5):443-7. PubMed ID: 4156307
[No Abstract] [Full Text] [Related]
7. Metabolic capabilities of the human fetus: drug biotransformation.
Juchau MR
Addict Dis; 1975; 2(1-2):37-43. PubMed ID: 1163372
[No Abstract] [Full Text] [Related]
8. Imipramine and chlorpromazine in hepatic microsomal systems.
Perel JM; O'Brien L; Black NB; Bellward GD; Dayton PG
Adv Biochem Psychopharmacol; 1974; 9(0):201-12. PubMed ID: 4836204
[No Abstract] [Full Text] [Related]
9. Dependence of microsomal methoxyflurane O-demethylation on cytochrome P-450 reductase and the stoichiometry of fluoride ion and formaldehyde release.
Waskell L; Gonzales J
Anesth Analg; 1982 Jul; 61(7):609-13. PubMed ID: 7201258
[TBL] [Abstract][Full Text] [Related]
10. Sex-dependent differences in drug metabolism in the rat. 3. Temporal changes in type I binding and NADPH-cytochrome, P-450 reductase during sexual maturation.
Cohen GM; Mannering GJ
Drug Metab Dispos; 1974; 2(3):285-92. PubMed ID: 4153061
[No Abstract] [Full Text] [Related]
11. Role of cytochrome P450 in oxazaphosphorine metabolism. Deactivation via N-dechloroethylation and activation via 4-hydroxylation catalyzed by distinct subsets of rat liver cytochromes P450.
Yu L; Waxman DJ
Drug Metab Dispos; 1996 Nov; 24(11):1254-62. PubMed ID: 8937861
[TBL] [Abstract][Full Text] [Related]
12. [Liver and metabolism of drugs].
Darnis F
Cah Med; 1974 Oct; 15(10):637-43. PubMed ID: 4455367
[No Abstract] [Full Text] [Related]
13. Interferon-mediated depression of cytochrome P-450-dependent drug biotransformation.
Singh G; Renton KW
Mol Pharmacol; 1981 Nov; 20(3):681-4. PubMed ID: 6173738
[No Abstract] [Full Text] [Related]
14. Adaptive responses of the liver to foreign compounds, with special reference to microsomal drug-matabolizing enzymes.
Wada O; Yano Y
Rev Environ Health; 1974; 1(4):261-82. PubMed ID: 4617260
[No Abstract] [Full Text] [Related]
15. Biotransformation of 6-methoxy-3-(3',4',5'-trimethoxy-benzoyl)-1H-indole (BPR0L075), a novel antimicrotubule agent, by mouse, rat, dog, and human liver microsomes.
Yao HT; Wu YS; Chang YW; Hsieh HP; Chen WC; Lan SJ; Chen CT; Chao YS; Chang L; Sun HY; Yeh TK
Drug Metab Dispos; 2007 Jul; 35(7):1042-9. PubMed ID: 17403915
[TBL] [Abstract][Full Text] [Related]
16. Experimental in vitro approach to the study of covalent associations.
Pantarotto C
Food Addit Contam; 1984; 1(2):131-46. PubMed ID: 6536525
[No Abstract] [Full Text] [Related]
17. Refresher courses in pharmacology. 4. The biotransformation of drugs.
Jenkins WL
J S Afr Vet Med Assoc; 1971 Sep; 42(3):211-6. PubMed ID: 5161402
[No Abstract] [Full Text] [Related]
18. Pre- and postnatal enzyme capacity for drug metabolite production.
Gillette JR; Stripp B
Fed Proc; 1975 Feb; 34(2):172-8. PubMed ID: 1090453
[TBL] [Abstract][Full Text] [Related]
19. Drug and fatty acid hydroxylation by solubilized human liver microsomal cytochrome P-450-phospholipid requirement.
Kaschnitz RM; Coon MJ
Biochem Pharmacol; 1975 Jan; 24(2):295-7. PubMed ID: 1111541
[No Abstract] [Full Text] [Related]
20. Metabolic kinetics of pseudoracemic propranolol in human liver microsomes. Enantioselectivity and quinidine inhibition.
Marathe PH; Shen DD; Nelson WL
Drug Metab Dispos; 1994; 22(2):237-47. PubMed ID: 8013280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
